Sustained Release Talazoparib Implants for Localized Treatment of BRCA1-deficient Breast Cancer

Belz, JE; Kumar, R; Baldwin, P; Ojo, NC; Leal, AS; Royce, DB; Zhang, D; van de Ven, AL; Liby, KT; Sridhar, S

Sridhar, S (reprint author), Northeastern Univ, Nanomed Sci & Technol Ctr, Boston, MA 02115 USA.; Sridhar, S (reprint author), Northeastern Univ, Dept Phys, Boston, MA 02115 USA.

THERANOSTICS, 2017; 7 (17): 4340

Abstract

Talazoparib, a potent PARP inhibitor, has shown promising clinical and pre-clinical activity by inducing synthetic lethality in cancers with germline ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索